- Training
- March 2024
- 2 Days
Global
From €2639EUR$2,900USD£2,263GBP
- Training
- March 2024
- 2 Days
Global
From €2912EUR$3,200USD£2,497GBP
- Webinar
- February 2024
- 90 Minutes
Global
From €335EUR$368USD£287GBP
- Training
- January 2024
- 2 Days
Global
From €2912EUR$3,200USD£2,497GBP
- Report
- January 2024
- 278 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Training
- December 2023
- 3 Days
Global
From €1341EUR$1,474USD£1,150GBP
- Training
- November 2023
- 2 Days
Global
From €2639EUR$2,900USD£2,263GBP
- Training
- October 2023
- 2 Days
Global
From €2063EUR$2,267USD£1,769GBP
- Webinar
- September 2023
- 90 Minutes
Global
From €321EUR$353USD£275GBP
- Training
- August 2023
- 2 Days
Global
From €2912EUR$3,200USD£2,497GBP
- Webinar
- July 2023
- 90 Minutes
Global
From €324EUR$355USD£277GBP
- Training
- May 2023
- 2 Days
Global
From €1677EUR$1,843USD£1,438GBP
- Training
- March 2023
- 2 Days
Global
From €1546EUR$1,699USD£1,326GBP
- Training
- March 2023
- 2 Days
Global
From €1677EUR$1,843USD£1,438GBP
- Webinar
- March 2023
- 90 Minutes
Global
From €437EUR$480USD£374GBP
- Training
- January 2023
- 2 Days
Global
From €1677EUR$1,843USD£1,438GBP
- Training
- March 2022
- 1 Day
Global
From €1182EUR$1,299USD£1,014GBP
- Webinar
- May 2019
- 90 Minutes
Global
- Training
- 90 Minutes
Global
- Training
- 60 Minutes
Global

The CGMP market is a subset of the pharmaceutical manufacturing industry, focusing on the production of drugs and other pharmaceutical products in accordance with Current Good Manufacturing Practices (CGMP). CGMPs are a set of regulations and guidelines issued by the US Food and Drug Administration (FDA) to ensure that pharmaceutical products are safe and effective. CGMPs cover all aspects of the manufacturing process, from raw materials to finished products, and include requirements for quality control, personnel training, and record keeping.
The CGMP market is highly competitive, with many large and small companies offering a variety of services. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Teva Pharmaceuticals, AstraZeneca, Bayer, and Eli Lilly. Show Less Read more